Soudeh Mostaghimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Soudeh Mostaghimi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Amadou K. S. Camara
Medical College of Wisconsin
1 shared publication - Beth A. Lopour
University of California
1 shared publication - Brian L. Fish
Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
1 shared publication - Daniel W. Shrey
Children's Hospital of Orange County
1 shared publication - Farnaz H. Foomani
University of Wisconsin–Milwaukee, Biophotonics Laboratory, Department of Electrical Engineering, Mi
1 shared publication - Jayashree Narayanan
Medical College of Wisconsin, Department of Physiology, Milwaukee, Wisconsin
1 shared publication
Latest Publications
- Open Access
- 14 March 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (3) , 801-813
Prediction of treatment response in infantile epileptic spasms syndrome using EEG phase–amplitude coupling
Objective: Treatment selection for infantile epileptic spasms syndrome (IESS) is complex and multifaceted, and currently no electroencephalogram (EEG) biomarkers can guide this decision by predicting treatment response. We tested the predictive value of phase–amplitude coupling (PAC) as IESS patients are known to have elevated PAC. Methods: We analyzed retrospective EEG recordings from 40 IESS patients, before and after treatment, and 20 healthy controls. Patients were classified as responders ( n = 25) or nonresponders ( n = 15) based on short‐term treatment outcomes. We measured PAC in each EEG using modulation index (MI) and mean vector length (MVL) and analyzed the relationship between pre‐ and posttreatment values and the ability of pretreatment values to predict response. Results: MI and MVL values decreased with treatment in almost all subjects. However, nonresponders had significantly higher pretreatment MI than responders ( p < 0.05), suggesting utility for predicting treatment response. Logistic regression modeling suggested that a 0.5‐unit decrease in ln(MI), which is approximately one IQR of the pretreatment ln(MI) values, results in a 3.5‐fold increase in odds of positive treatment response. MI reflects short‐term treatment response and is a candidate predictive EEG biomarker for IESS. Significance: MI may offer individualized insights for treatment selection and management strategies for IESS. Plain Language Summary: We examined brain activity in infants with infantile epileptic spasms syndrome (IESS) to predict which infants' seizures would stop with standard medication. Specifically, we measured coupling between slow and fast brain waves in both healthy infants and those with IESS. Infants for whom medication failed had stronger coupling, even before the treatment was started, while those with weaker coupling (more similar to healthy infants) were more likely to have their seizures stop after treatment. These findings suggest that brain wave coupling could help doctors predict which infants will need more aggressive treatment.
- 14 March 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (3) , 801-813
Open AccessPrediction of treatment response in infantile epileptic spasms syndrome using EEG phase–amplitude coupling
Objective: Treatment selection for infantile epileptic spasms syndrome (IESS) is complex and multifaceted, and currently no electroencephalogram (EEG) biomarkers can guide this decision by predicting treatment response. We tested the predictive value of phase–amplitude coupling (PAC) as IESS patients are known to have elevated PAC. Methods: We analyzed retrospective EEG recordings from 40 IESS patients, before and after treatment, and 20 healthy controls. Patients were classified as responders ( n = 25) or nonresponders ( n = 15) based on short‐term treatment outcomes. We measured PAC in each EEG using modulation index (MI) and mean vector length (MVL) and analyzed the relationship between pre‐ and posttreatment values and the ability of pretreatment values to predict response. Results: MI and MVL values decreased with treatment in almost all subjects. However, nonresponders had significantly higher pretreatment MI than responders ( p < 0.05), suggesting utility for predicting treatment response. Logistic regression modeling suggested that a 0.5‐unit decrease in ln(MI), which is approximately one IQR of the pretreatment ln(MI) values, results in a 3.5‐fold increase in odds of positive treatment response. MI reflects short‐term treatment response and is a candidate predictive EEG biomarker for IESS. Significance: MI may offer individualized insights for treatment selection and management strategies for IESS. Plain Language Summary: We examined brain activity in infants with infantile epileptic spasms syndrome (IESS) to predict which infants' seizures would stop with standard medication. Specifically, we measured coupling between slow and fast brain waves in both healthy infants and those with IESS. Infants for whom medication failed had stronger coupling, even before the treatment was started, while those with weaker coupling (more similar to healthy infants) were more likely to have their seizures stop after treatment. These findings suggest that brain wave coupling could help doctors predict which infants will need more aggressive treatment.
- Open Access
- 8 July 2021
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 26 (07) , 076002-16
Three-dimensional vascular and metabolic imaging using inverted autofluorescence
Damaged vasculature and the resulting impaired blood circulation in organs can cause pathological injuries, such as organ failure and stroke.1 Therefore, vascular imaging plays a pivotal role in diagnosis, follow-up of disease progression, and assessment of treatment efficacy.2 Assessment of vascular structure in rodent models is key to quantitate organ vasculature.3,4 This quantitation could be beneficial in analyzing pathological conditions, such as hypertension,5 diabetes,6 and retinopathy7 as well as changes induced by environmental or chemical agents such as radiation8 or drugs.9 Vascular imaging is also important to study therapeutic angiogenesis.10
- 8 July 2021
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 26 (07) , 076002-16
Open AccessThree-dimensional vascular and metabolic imaging using inverted autofluorescence
Damaged vasculature and the resulting impaired blood circulation in organs can cause pathological injuries, such as organ failure and stroke.1 Therefore, vascular imaging plays a pivotal role in diagnosis, follow-up of disease progression, and assessment of treatment efficacy.2 Assessment of vascular structure in rodent models is key to quantitate organ vasculature.3,4 This quantitation could be beneficial in analyzing pathological conditions, such as hypertension,5 diabetes,6 and retinopathy7 as well as changes induced by environmental or chemical agents such as radiation8 or drugs.9 Vascular imaging is also important to study therapeutic angiogenesis.10